Impact of the Ki-67 proliferation index on response to peptide receptor radionuclide therapy

Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors

(2009) Jonathan Strosberg et al.   HUMAN PATHOLOGY

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogs

(2009) Dik J. Kwekkeboom et al.   NEUROENDOCRINOLOGY

PET-CT bei neuroendokrinen Tumoren und nuklearmedizinische Therapiemöglichkeiten

(2009) K. Scheidhauer et al.   RADIOLOGE

Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors

(2008) Ulrich‐Frank Pape et al.   CANCER

Functional imaging of neuroendocrine tumors with combined PET/CT using68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and18F-FDG

(2008) Irfan Kayani et al.   CANCER

Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours

(2008) U.-F. Pape et al.   ENDOCRINE-RELATED CANCER

Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival

(2008) Dik J. Kwekkeboom et al.   JOURNAL OF CLINICAL ONCOLOGY